Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients

about

Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment.Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature.

P2860

Q48166426-686967ED-0115-416B-9005-C927895A9825 Q49165503-CE49D671-1379-47D8-86FF-55E64400E8B4

P2860

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients

Item

http://www.wikidata.org/entity/Q41584205

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Changes of Bone-Related Minera ...... nopausal Osteoporotic Patients

@en

type

Item

label

Changes of Bone-Related Minera ...... nopausal Osteoporotic Patients

@en

prefLabel

Changes of Bone-Related Minera ...... nopausal Osteoporotic Patients

@en

P1476

Changes of Bone-Related Minera ...... nopausal Osteoporotic Patients

@en

P2093

Hiroyuki Kato

http://www.w3.org/2001/XMLSchema#string

Takako Suzuki

http://www.w3.org/2001/XMLSchema#string

Yukio Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis

Skeletal and hormonal effects of magnesium deficiency

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Iron deficiency negatively affects vertebrae and femurs of rats independently of energy intake and body weight.

Dietary magnesium intake and fracture risk: data from a large prospective study.

Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary.

Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.

Cytochrome P450-mediated metabolism of vitamin D.

Denosumab in osteoporosis.

P31

scholarly article

P356

10.3390/NU9080871

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28805705

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

5579664

http://www.w3.org/2001/XMLSchema#string

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients

about

P2860

P2860

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932